Patents by Inventor Jeffrey C. Edman

Jeffrey C. Edman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6627733
    Abstract: A breast carcinoma tyrosine phosphoprotein, DDR (Discoidin Domain Receptor), that defines a novel class of receptor tyrosine kinases is presented. The DDR cDNA predicts a polypeptide C-terminal tyrosine kinase domain and an N-terminal domain similar to the Dictyostelium discoideum lectin discoidin I. These domains are connected by an extraordinary hydrophilic proline/glycine-rich domain, which is interrupted by a predicted transmembrane sequence. This extended proline/glycine-rich region suggests an unusual geometry of interaction with ligand or substrates. Discoidin I-type domains may interact with specific cell surface molecules.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: September 30, 2003
    Inventors: Jeffrey D. Johnson, William J. Rutter, Jeffrey C. Edman
  • Publication number: 20030124133
    Abstract: A breast carcinoma tyrosine phosphoprotein, DDR (Discoidin Domain Receptor), that defines a novel class of receptor tyrosine kinases is presented. The DDR cDNA predicts a polypeptide C-terminal tyrosine kinase domain and an N-terminal domain similar to the Dictyostelium discoideum lectin discoidin I. These domains are connected by an extraordinary hydrophilic proline/glycine-rich domain, which is interrupted by a predicted transmembrane sequence. This extended proline/glycine-rich region suggests an unusual geometry of interaction with ligand or substrates. Discoidin I-type domains may interact with specific cell surface molecules.
    Type: Application
    Filed: August 26, 1998
    Publication date: July 3, 2003
    Inventors: JEFFREY D. JOHNSON, WILLIAM J. RUTTER, JEFFREY C. EDMAN
  • Patent number: 5145782
    Abstract: A DNA expression vector is described which is derived from the highly efficient trp operon. The expression vector provides for the direct expression of an inserted gene or cDNA. Using the expression vector described herein, it is possible to obtain the protein coded by the gene or cDNA directly and not as a fusion protein. The expression vector comprises the promoter, operator and leader ribosomal binding site of the trp operon.
    Type: Grant
    Filed: November 17, 1987
    Date of Patent: September 8, 1992
    Assignee: The Regents of the University of California
    Inventors: Robert A. Hallewell, Jeffrey C. Edman, William J. Rutter, Howard M. Goodman
  • Patent number: 4820642
    Abstract: A DNA expression vector which contains the trp promotor is described. The expression vector provides for the overproduction of .beta.-lactamase. Insertion of a gene or cDNA into the .beta.-lactamase gene of the expression vector results in the over-production of a fusion protein comprising a part of the .beta.-lactamase as the N-terminal end and the protein coded for by the inserted DNA as the C-terminal end. Using the expression vector described herein, it is possible to obtain large amounts of the fusion protein. A fusion protein containing the surface antigen of Hepatitis B virus and a vaccine containing this fusion protein are also described.
    Type: Grant
    Filed: April 4, 1983
    Date of Patent: April 11, 1989
    Assignee: The Regents of the University of California
    Inventors: Jeffrey C. Edman, William J. Rutter, Robert A. Hallewell, Pablo D. T. Valenzuela, Howard M. Goodman